Related Experiment Video
Updated: Jun 24, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
Nutritional considerations with antiobesity medications
Jaime P Almandoz1, Thomas A Wadden2, Colleen Tewksbury3
1Division of Endocrinology, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
New antiobesity medications (AOMs) offer significant weight reduction. This review provides practical nutritional guidance for clinicians to support patients during AOM treatment, ensuring optimal outcomes.
Area of Science:
- Obesity Medicine
- Nutritional Science
Background:
- Emerging antiobesity medications (AOMs) demonstrate improved efficacy and safety.
- These medications achieve an average weight reduction of ≥15%, marking a significant advancement in obesity treatment.
Purpose of the Study:
- To offer evidence-based recommendations for nutritional assessment, management, and monitoring of patients undergoing AOM treatment.
- To guide clinicians in supporting patients to optimize health and well-being during AOM therapy.
Main Methods:
- This narrative review synthesizes current evidence on nutritional considerations for AOMs.
- Recommendations cover pre-treatment assessment, counseling on nutrient intake, and ongoing monitoring during AOM therapy.
Main Results:
- Pre-treatment assessment should identify nutritional risks and guide counseling on protein, fiber, micronutrients, and fluids.
- Ongoing monitoring is crucial for managing gastrointestinal symptoms and ensuring adequate nutrient/fluid intake.
- Holistic patient support should include physical activity, social, and emotional health aspects.
Conclusions:
- Clinicians play a vital role in supporting patients with obesity during AOM treatment.
- Optimizing nutritional status and addressing lifestyle factors enhance treatment response and quality of life.
- Comprehensive management promotes optimal nutritional and medical outcomes for patients on AOMs.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Obesity
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...

